| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On August 15, 2007
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 2007D-0185
|
| Guidance for Industry and Review Staff on Labeling for Human Prescription Drugs Determining Established Pharmacologic Class for Use in the Highlights of Prescribing Information
|
|
|
|
|
| 2007D-0213
|
| Guidance for Industry on Providing Regulatory Submissions in Electronic Format Receipt Date
|
|
|
|
|
| 2007P-0322
|
| FDA not to
grant final Approval or further tentative approvals to any generic versions
of Pioglitazone Hydrochloride that is not labeled both monotherapy and
combination therapy in the same manner as
|
|
|
|
|
|
| 2007V-0315
|
| Projector for a Laser Light Show
|
|
| |
|
| 2007D-0185
|
| Guidance for Industry and Review Staff on Labeling for Human Prescription Drugs Determining Established Pharmacologic Class for Use in the Highlights of Prescribing Information
|
|
|
|
|
|
|
|
|
| C 2
|
| American Society of Health-System Pharmacists
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007D-0213
|
| Guidance for Industry on Providing Regulatory Submissions in Electronic Format Receipt Date
|
|
|
|
|
| C 3
|
| PhRMA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007P-0322
|
| FDA not to grant
final Approval or futher tentative approvals to any generic versions
of Pioglitazone Hydrochloride that is not labeled both monotherapy and
combination therapy in the same manner as
|
|
|
|
|
|
| |
|
|
|
| ACK 1
|
| FDA/DDM to Arnold & Porter LLP
|
| Vol #:
|
| 1
|
|
|
|
|
| CP 1
|
| Arnold & Porter LLP
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007V-0315
|
| Projector for a Laser Light Show
|
|
|
|
|
| CR 1
|
| FDA
|
| Vol #:
|
| 1
|
|
